Clinithink

Who We Are:

Founded in 2009, Clinithink is a market leading clinical natural language processing (CNLP) software supplier that gives life sciences organizations and healthcare providers coveted access to valuable unstructured clinical narrative. We value data-driven innovation in healthcare and have a proven track record of helping our clients and partners automate and accelerate patient enrollment in clinical trials.

Contact Information

Clinithink
555 Northpoint Center East, 4th Floor
Alpharetta, GA 30022
USA
info@clinithink.com
www.clinithink.com/
View Map

What We Offer:

SUBJECT RECRUITMENT

Clinithink automates and accelerates the search for eligible patients to enroll in clinical studies.

Clinithink automates and accelerates the search for quality cohorts of eligible candidates that meet trial-specific in- and exclusion criteria.

Clinithink automates and accelerates clinical trial pre-screening to identify quality cohorts of highly eligible patients to recruit faster and more cost effectively.

Clinithink is leading a paradigm shift in how sites find highly eligible patients to enroll in clinical trials by harnessing true automation to search existing clinical narrative data.

Other uses for CLiX ENRICH

FEASIBILITY & SITE SELECTION

Controlling time and costs are paramount in clinical trials. Feasibility study assessment using CLiX ENRICH for Clinical Trials provides additional sources of data with rich patient information to expand the pool of potentially eligible patients in close proximity to known sites. Robust clinical data insights enabled by Clinithink can support more accurate and effective protocol design to mitigate risks before costly adjustments need to be made, while also providing data transparency across sponsor, contract research organization (CRO) and trial sites.

PHARMACOVIGILANCE

Once a drug, device or treatment has been approved, pharmaceutical companies are obligated to capture data related to the detection, assessment, understanding and prevention of adverse effects. During Phase IV of clinical trials or pharmacovigilance/post-market surveillance, the ability to identify trends by monitoring actual use is handled manually by sorting through vast amounts of scattered unstructured text in EMRs, clinical documentation systems, registries and more. The power of CLiX ENRICH for Clinical Trials enables an automated method to vigilantly monitor, assess, analyze and manage risk beyond base compliance requirements for rigorous risk evaluation and mitigation strategies (REMS).

WHITE PAPER: A PARADIGM SHIFT IN PATIENT RECRUITMENT FOR CLINICAL TRIALS

Although much of the world and other industries have adopted technology solutions which have saved time and money, and arguably, improved our lives, Healthcare is a laggard. This White Paper describes how Investigative Sites can update their recruitment strategies to automate and accelerate patient pre-screening. An innovative technology solution proven to find 10x times more patients meeting clinical trial inclusion and exclusion criteria in a fraction of the time it takes using the decades-old traditional methods.

CASE STUDY: MOUNT SINAI RETROSPECTIVE TRIAL IN PATIENT GROUP WITH RARE KIDNEY DISEASE

In a fraction of the time, CLiX ENRICH found many more eligible patients than we did.”- Girish N. Nadkarni, MD, Clinical Instructor of Medicine/Nephrology at Mount Sinai.

STUDY SUMMARY

This project demonstrates the unique advantage offered by CLiX ENRICH in clinical trials where recruitment can be most challenging. With two weeks of focused resource use, CLiX queries can be authored and run against large volumes of data to provide an ENRICHed List of highly eligible patients for recruitment. By directing the investigators towards relevant patients in the ENRICHed List, enrollment numbers can be significantly increased in a markedly shorter timeline.

Contact Information

Clinithink
555 Northpoint Center East, 4th Floor
Alpharetta, GA 30022
USA
info@clinithink.com
www.clinithink.com/
View Map

Contact Company

If you are interested in contacting this company, please complete and submit the form below. A representative from the company will follow up with you.